COMMUNIQUÉS West-GlobeNewswire
-
SAFE - Informations complémentaires concernant le report de publication des résultats annuels 2024
31/07/2025 -
ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China
31/07/2025 -
Integra LifeSciences Reports Second Quarter 2025 Financial Results
31/07/2025 -
PL BioScience Announces Major Site Expansion
31/07/2025
Pages